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Spectroscopic methods, which are used to establish RNA structure-function 
relationships, require strategies for post-synthetic, site-specific incorporation of chemical 
probes into target RNAs. For RNAs larger than 50 nucleotides (nt), the enzymatic 
incorporation of a nucleoside or nucleoside monophosphate guanosine analog (G-
analog) at their 5'-end is routinely achieved by T7 RNA polymerase (T7RNAP)-mediated 
in vitro transcription (IVT) of the appropriate DNA template containing a GTP-initiating 
class III Φ6.5 promoter. However, when high G-analog:GTP ratios are used to bias G-
analog incorporation at the 5'-end, RNA yield is compromised. Here, we show that the 
use of a T7RNAP Pro266Leu mutant in an IVT with 10:1 thienoguanosine (thG, a 
fluorescent guanosine surrogate):GTP increased the percent incorporation and yield of 
5'-thG-initiated precursor tRNA for a net three-fold gain compared to an IVT with wild-
type T7RNAP. We also demonstrate that a one-pot multi-enzyme (OPME) approach, 
consisting of transcription by T7RNAP Pro266Leu and post-transcriptional cleanup by a 
polyphosphatase and an exonuclease, led to essentially near-homogeneous 5'-thG-
modified transcripts. We also validated the broader utility of our one-pot multi-enzyme 
approach to initiate RNAs with an azide-bearing G-analog, an undertaking that 
necessitated the development an RNase P (a tRNA 5′-maturation endonuclease)-based 
assay to accurately determine the percentage of 5'-azide-initiated RNA. The OPME 
approach, coupled with use of T7RNAP Pro266Leu,  should be of broad utility in 
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Chapter 1: Introduction* 
1.1: The biological importance of RNA 
The central dogma of biology, proposed nearly 60 years ago, describes the flow of 
genetic information from deoxyribonucleic acid (DNA) to ribonucleic acid (RNA) to 
proteins. Although this framework envisioned RNA as a docile intermediary in 
information transfer, this notion has been upended by the diversity of RNA functions 
(e.g., catalysis, chromatin remodeling, structural scaffolds) recognized over the last 30 
years.[1,2] These discoveries have motivated a wide gamut of studies spanning RNA’s 
central role in evolution (‘RNA world hypothesis’)[3,4] to its contribution to diseases.[5] 
Along with an appreciation of RNA’s broad functional scope, there has been progress in 
developing chemically-modified RNAs that could serve as either drug carriers as well as 
the design of small-molecule inhibitors to target RNAs implicated in disease.[6-8] Clearly, 
progress in these efforts to understand and manipulate RNA function requires 
knowledge of its structure, which in turn necessitates the development of toolkits that 
will allow facile probing of structure-function relationships of RNAs.[9-13] These toolkits 
typically seek to generate an RNA with a site-specific biophysical probe that in turn 
permits investigation of RNA structure under various conditions. 
 
1.2: Methods to incorporate chemical probes into RNA 
A suite of post-synthetic strategies is available to introduce chemical modifications to 
RNAs. Hybridization of a chemically-modified DNA or peptide nucleic acid (PNA) 
oligomer to an RNA is one approach to indirectly introduce fluorophores or chemical 
15 
modifications to an RNA of interest.[9-12,14] While this method is facile and an array of 
chemically-modified DNA/PNA oligomers are commercially available, it limits the probe 
to be present at only single-stranded regions of an RNA[9-12,14] and it is possible that 
binding of the probe interferes with RNA function.  
Periodate oxidation offers a route to post-synthetically introduce direct chemical 
modifications to the 3' terminus of a target RNA.[9,10] This method entails the use of 
sodium periodate to oxidize the 2',3'-diol at the 3' terminus of the RNA to yield a reactive 
dialdehyde, which can be subsequently coupled to an amine-bearing fluorophore or 
other reactive group. Enzymes such as T4 polynucleotide kinase (PNK) and poly(A)-
polymerase have also been utilized to introduce chemical modifications at the 5' and 3' 
termini, respectively, of RNAs. T4 PNK has specifically been used to transfer the γ-
phosphorothioate of ATPγS to the 5'-hydroxyl of the target RNA while poly(A)-
polymerase adds a 3'-deoxy ATP analog to the 3' hydroxyl of the target RNA.[9,13] 
Although these methods are typically high yielding, they necessitate an additional 
processing step. 
To date, there have been two reports that demonstrate the use of a capping 
enzyme from the Vaccina virus, which catalyzes attachment of a m7G cap the 5'-end of 
an RNA through a 5'-5' triphosphate bridge, to post-synthetically introduce chemical 
modifications to the 5'-terminus in a target RNA. The first study utilized the Vaccina 
Capping Enzyme (VCE) to attach a 3'-anthraniloyl m7GTP to produce fluorescent RNA 
and moreover, reported that the capping efficiency was, in some instances, 
indistinguishable from that of GTP, to generate a fluorescent RNA.[15] The second report 
used VCE to attach a 3'-biotin-GTP to the 5'-end of target mRNAs and while they did 
16 
not report the capping efficiency, they did note that VCE does not accept GMP or 2'-
biotin-modified GTP substrates.[16] 
The incorporation of a chemical modification during synthesis of an RNA offers a 
more convenient route to modify RNA. For small RNAs (less than 50 nt), solid-phase 
synthesis is typically used to site-specifically introduce chemical modifications to both 
the 5' and 3' termini as well as at an internal position in a target RNA.[9,10] Although 
solid-phase synthesis allows for direct chemical modification of RNA, it also entails the 
non-trivial synthesis of a phosphoramidite-bearing NTP analog and is inefficient when 
generating RNAs larger than 50 nt, a size barrier that is slowly being breached.[17] While 
the site-specific incorporation of a nucleotide analog during the enzymatic synthesis of 
RNA through in vitro transcription (IVT) of a DNA template containing unnatural DNA 
base-pairs has been achieved,[18-21] the yield of RNA and/or incorporation of the 
nucleotide analog is typically poor.[18,20] However, the Ellington laboratory recently 
reported that use of a T7 RNA polymerase (T7RNAP) with eight mutations, dubbed 
‘VRS-M5’, improved the yield and percent incorporation of a Cy3-bearing ATP analog 
when transcribing a DNA template with an unnatural base-pair.[21] 
 
1.3: Statement of the problem and workplan 
The enzymatic method for site-specifically introducing chemically-modified 
nucleoside/nucleotide monophosphate analogs at the 5'-terminus of an RNA generated 
by IVT is particularly attractive due to its low cost and applicability to RNAs of any 
length. Bacteriophage-derived RNA polymerases (e.g., SP6, T3, T7) have long been 
17 
used to synthesize RNAs, with T7RNAP being a well-established and preferred 
choice.[22-24] A desired RNA is generated by placing the sequence of interest 
immediately downstream of the 17-bp T7RNAP promoter and by performing an IVT with 
recombinant, single-polypeptide T7RNAP. This approach, coupled with the Moore-
Sharp ligation method, can also be used to generate RNAs with an internal label 
provided the nucleoside analog has a 5'-hydroxyl available.[25,26] In this scheme, an IVT 
is used to generate two partial transcripts, which upon ligation will yield the desired full-
length RNA. The first partial RNA transcript is designed to span from the 5'-terminus of 
the full-length RNA to one nucleotide before the desired site of internal modification; the 
second partial transcript is designed to initiate with the desired modification and 
terminate at the 3'-end of the full-length RNA. A DNA oligonucleotide, which serves as a 
splint that is complementary to the junction spanning the two partial transcripts, enables 
T4 DNA ligase to ligate the two RNAs and yield the full-length RNA with a site-specific 
internal modification.[25.26] 
While there are many T7RNAP promoter variants, the commonly employed class 
III Φ6.5 promoter allows high transcriptional yields when the RNA is initiated with two 
guanosines (Gs).[22-24] Several investigators[27-36] have exploited this attribute to bias 
T7RNAP to initiate with G-analogs (Table 1.1), which can support initiation but not 
elongation since they lack a triphosphate. Despite the remarkable tolerance of T7RNAP 
to utilize non-native purine mimics as initiators, an intrinsic limitation of this approach is 
the low yield of RNA resulting from: (i) the use of high G-analog:GTP ratios (up to 
100:1) in the IVTs, and (ii) a large fraction of the RNAs initiated with G-analogs finishing 
up as aborted transcripts. Here, we sought to address these limitations. 
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In this thesis, I show that the use of a T7RNAP Pro266Leu (P266L) mutant with a 
decreased propensity for abortive transcription enhances yield and incorporation of the 
G-analog. Moreover, we used moderate G-analog:GTP ratios (10:1) during IVTs to help 
enhance the yield of RNAs initiated with GTP and the G-analog, but then employed a 
post-transcriptional (one-pot) enzymatic clean-up to selectively eliminate 5'-GTP-
initiated RNAs. Overall, this simple approach solves a long-standing problem to prepare 
5'-modified RNAs with high yield and purity.  
I also present a novel RNase P-based assay that was developed to directly 
assess the percent incorporation of non-fluorescent G-analogs at the 5'-terminus of a 
pre-tRNA. Importantly, this assay can also be adapted to assess percent incorporation 













Table 1.1: Previously studied guanosine analogs 
G-analog G-analog:GTP ratio 
Percent incorporation 






5:1 52% 9 nt 27 
 
4:1 100% 66 nt 28 
5:1 36% 75 nt 29 
 
31:1 40% 82 nt 30 
 






Table 1.1 continued 
G-analog G-analog:GTP ratio 
Percent incorporation 






8:1 60% 192 nt 32 
 
18:1 60% 82 nt 33 
 
10:1 70% 19 nt 34 
 




Table 1.1 continued 
 
 
Names of compounds listed above: i) thienoguanosine, ii) 5'-deoxy-5'-azidoguanosine, iii) 5'-deoxy-5'-
hydrazinylguanosine, iv) 5'-guanosine-5'-monophosphorothioate, v) 5'-deoxy-5'-thioguanosine-5'-monophosphorothioate, 
vi) 5'-deoxy-5'-aminoguanosine-N-phosphoramidate, vii-x): see references for formal chemical names.
G-analog G-analog:GTP ratio 
Percent incorporation 






10:1 75% 109 nt 35 
 
5:1 80% 25 36 
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Chapter 2: A T7 RNA polymerase mutant enhances the yield of  
5'-thienoguanosine-initiated RNAs** 
2.1: Background and rationale 
To obtain a high yield of full-length RNAs containing a G-analog at the 5'-end, we chose 
a test G-analog and examined a set of modified IVT conditions. Three reasons inspired 
our choice of thienoguanosine (thG; Figure 2.1), a fluorescent guanosine surrogate,[1,2] 
as the pilot analog. First, thG permits facile fluorescence detection[1] post-synthesis, thus 
allowing us to rapidly examine different IVT conditions and fine-tune variables as 
needed. Second, optimizing 5'-incorporation is expected to have payoffs for site-specific 
(internal) modification because 5'-thG-modified RNAs can be 5'-phosphorylated and 
ligated to another RNA to yield the desired longer RNA with an internal thG.[2] Finally, 
given the value of emissive nucleoside analogs as bona fide isomorphs, methods to 
enhance incorporation of these isomorphs into RNAs will greatly aid mechanistic and 
spectroscopic studies, as was demonstrated elegantly in a recent study of the 
hammerhead ribozyme.[2] As a model RNA for our IVTs, we used a 155-nt precursor-
tRNACys (pre-tRNACys; Figure 2.2). 
We considered various modifications to the IVT conditions to increase 
incorporation of the G-analog. Foremost, based on the premise that poor IVT yields 
arise from the rapid depletion of limited GTP, which is typically used at low 
concentrations to favor incorporation of the modified G-analog, Katie Adib, a previous 
undergraduate in the Gopalan laboratory, used a phased-addition strategy wherein GTP 
was supplemented at timed intervals. Although this approach engendered 5'-












Figure 2.2: Secondary structure of pre-tRNACys, the model RNA used in this study. 
The sequences of the 5’-leader and 3’-trailer are provided below the secondary 
structure. 
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included varying concentrations of Mn2+ in the IVT to influence T7RNAP fidelity[4,5] and 
thereby favor the G-analog over GTP, but these attempts were unsuccessful. Results 
from these studies revealed that abortive transcription is a critical roadblock, and 
inspired us to consider the use of T7RNAP mutants that have been shown to increase 
incorporation of various 2'-modified NTP-analogs into RNAs synthesized during IVTs.[6-9] 
From this panel of mutants, we chose T7RNAP P266L because kinetic and footprinting 
studies revealed that this mutant exhibits a delayed transition from transcriptional 
initiation to elongation and generates fewer aborted transcripts, an attribute that stems 
from the enhanced stability of the longer DNA:RNA hybrid in its initiation complex.[10-13] 
We sought to test the postulate that the T7RNAP P266L mutant would decrease 
aborted transcripts typically observed when 5'-G-analogs are used with T7RNAP wild-
type (WT; Figure 2.3). The problem of low G-analog incorporation, however, 
necessitates a combination of transcriptional and post-transcriptional strategies since a 
fraction of transcripts will always be initiated with GTP. Therefore, we investigated the 
utility of a one-pot multi-enzyme (OPME) approach wherein a clean-up step (post-
transcription with T7RNAP P266L) with a polyphosphatase and an exonuclease is used 
in tandem to selectively degrade the 5'-GTP-initiated RNAs and yield near-
homogeneous 5'-thG-initiated RNAs (Figure 2.4).  
2.2: Materials and methods 
2.2.1: Overexpression and purification of T7RNAP WT 
The purification of T7RNAP WT exploited immobilized metal affinity-chromatography and 






Figure 2.3: Schematic of the expected outcomes from IVTs with a fixed ratio of thG:GTP 
and performed with either T7RNAP WT or the P266L mutant. This illustration depicts 







Figure 2.4: Comparison of a typical IVT versus the one-pot multi-enzyme approach 
designed to eliminate 5’-GTP-initiated RNAs. 
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below. Escherichia coli BL21(DE3) cells were transformed with two plasmids: pQE9T7 
(ampr) and pREP4 (kanr) which encode (His)6-T7RNAP WT and lac repressor, 
respectively, and grown on a lysogeny broth (LB) agar plate containing 100 μg/mL 
carbenicillin and 35 μg/mL kanamycin at 37°C for 16 h. A single colony was picked to 
inoculate 5 mL of LB containing 100 μg/mL carbenicillin and 35 μg/mL kanamycin, and 
grown at 37°C for 16 h with shaking at 200 rpm. The 5-mL culture was then used to 
inoculate 500 mL of LB containing 100 μg/mL carbenicillin and 35 μg/mL of kanamycin, 
and grown at 37°C with shaking at 200 rpm until OD600 ~0.6. The culture was induced 
by addition of isopropyl-ß-D-thiogalactoside (IPTG) to a final concentration 1 mM and 
then grown at 37°C for an additional 2.5 h. Cells were harvested by centrifugation at 
6,000 g for 20 min, and the pellets stored at -80°C until further use.  
A 500-mL cell pellet was thawed on ice and then resuspended in buffer A [100 
mM sodium phosphate (pH 7.7), 300 mM NaCl, 0.5 mM DTT, 1 mM PMSF, 2 mini 
EDTA-free protease inhibitor tablets (Roche)]. Cells were lysed by sonication (60% 
amplitude, 12-min of alternating cycles of 4 s ON and 10 s OFF; Cole Parmer 130-Watt 
Ultrasonic Processor model GEX130) and the crude lysate was subjected to 
centrifugation at 20,000 g for 1 h at 4°C. The supernatant obtained was filtered through 
a 0.45 μm syringe filter. After addition of 20 mM imidazole to the filtered supernatant, it 
was loaded onto a pre-equilibrated 5-mL HisTrap HP (GE Healthcare) column. An 
ATKA FPLC (GE Healthcare) was used for the subsequent elution. The column was 
washed with 50 mL buffer B [100 mM sodium phosphate (pH 7.7), 300 mM NaCl, 0.5 
mM DTT, 1 mM PMSF, 20 mM imidazole], and T7RNAP WT was eluted using a 100-ml 
linear gradient from 20-300 mM imidazole at a flow rate of 3 mL/min. T7RNAP WT 
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typically eluted between 170-210 mM imidazole. Peak fractions, as judged by SDS-
PAGE analysis, were pooled and subsequently dialyzed against 500 mL of buffer C [50 
mM sodium phosphate (pH 7.7), 100 mM NaCl, 1 mM DTT, 0.1 mM PMSF, 1 mM EDTA 
and 50% (v/v) glycerol] at 4°C overnight after one buffer exchange after 2 h. Aliquots of 
the purified T7RNAP (dialysate) were stored at -80°C until further use in in vitro 
transcriptions (IVTs). 
 
2.2.2: Overexpression and purification of T7RNAP P266L 
The overexpression and purification of (His)6-T7RNAP P266L was based on a protocol 
kindly provided by the laboratory of Prof. Thomas A. Steitz, Yale University,[10] with 
some notable modifications (exclusion of a polishing step as well as dialysis and final 
preparative steps). E. coli BL21(DE3) cells were transformed with pBH161 (a gift from 
the Steitz laboratory), which encodes (His)6-T7RNAP P266L, and grown on an LB-agar 
plate containing 50 μg/mL carbenicillin at 37°C for 16 h. A single colony was picked to 
inoculate 5 mL of Terrific Broth (TB) containing 50 μg/mL carbenicillin and the culture 
was grown at 37°C for 16 h with shaking at 200 rpm. This 5-mL seed culture was added 
to 500 mL of TB containing 50 μg/mL carbenicillin and grown at 37°C with shaking at 
200 rpm until OD600 ~1. Next, carbenicillin was supplemented to a final concentration of 
100 μg/mL and the culture induced with 1 mM IPTG at 37°C for 4 h. Cells were 
harvested (as described above for WT) and the pellets stored at -80°C.  
For purification of T7RNAP P266L, a 500-mL cell pellet was thawed on ice and 
then resuspended in buffer D [10 mM Tris-HCl (pH 8.0), 375 mM NaCl, 0.5 mM DTT, 1 
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mM PMSF, 2 mini EDTA-free protease inhibitor tablets (Roche)]. Subsequent steps 
mirrored the T7RNAP WT procedure described above with the exception of use of a 1-
mL HisTrap (GE Healthcare) column. After washing with 10 mL of buffer E [10 mM Tris-
HCl (pH 8.0), 375 mM NaCl, 0.5 mM DTT, 1 mM PMSF, 20 mM imidazole], T7RNAP 
P266L was eluted using a 12-ml linear gradient from 20-200 mM imidazole. T7RNAP 
P266L typically eluted between 140-180 mM imidazole. Peak fractions, as assessed by 
SDS-PAGE analysis, were pooled and subsequently dialyzed in 500 mL of buffer F [100 
mM sodium phosphate (pH 7.7), 200 mM NaCl, 2 mM DTT, 0.2 mM PMSF, 2 mM 
EDTA] at 4°C for 3 h with buffer exchanges every hour. An equal volume of glycerol 
was added to the dialysate and the solution was mixed at 4°C using a nutator. Aliquots 
of the purified T7RNAP P266L [in 50% (v/v) glycerol)] were stored at -80°C until further 
use. 
 
2.2.3: In vitro transcription reactions 
A PCR DNA template containing a class III Φ6.5 promoter and gene encoding 
Arabidopsis thaliana mitochondrial precursor tRNACys was prepared as previously 
described.[15] This pre-tRNA has a 55-nt 5'-leader and a 23-nt 3'-trailer (see Figure 2.2), 
and was chosen due to its availability and use in our laboratory for studies of RNase P. 
One hundred-µl IVTs were performed at 37°C for 5 h in 80 mM HEPES (pH 7.5), 1 mM 
spermidine, 33 mM MgCl2, 5% (v/v) DMSO, 3 mM ATP, 3 mM CTP, 3 mM UTP, 0.2 U of 
thermostable inorganic pyrophosphatase [New England Biolabs (NEB), Ipswich, MA], 
400 ng of DNA template and approximately 2 µg of either T7RNAP WT or P266L. IVTs 
containing thG were performed using 4.8 mM thG and 0.48 mM GTP (10:1 ratio). Post-
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transcription, the DNA template was degraded by addition of 10 U of DNase I (Roche, 
Basel, Switzerland) and incubation at 37°C for 30 min. 
 
2.2.3: Post-transcriptional removal of 5'-ppp RNAs 
For the OPME approach, 5 U of the RppH polyphosphatase (NEB) and NaCl (to a final 
concentration of 50 mM) was added to the DNase I-treated IVT reaction and incubated 
for 1.5 h at 37°C. Subsequently, 1 U of the Xrn-1 exonuclease (NEB) and NaCl (to a 
final concentration of 100 mM) was added to the reaction and incubated for 1.5 h at 
37°C. To ensure higher Xrn-1 activity, we increased the temperature to 45°C for 5 s 
every 5 min; these reactions were performed using a thermal cycler.  
Post-transcription and RNA processing, all reactions were subjected to a phenol-
chloroform extraction and subsequently to a Zymo Clean and ConcentratorTM-25 (Zymo 
Research, Irvine, CA) to remove unincorporated nucleotides and short, abortive 
transcripts <18 nt in length (Figure 2.5). Total RNA yield was determined using Abs260 
measurements on a NanoDrop 2000c spectrophotometer and the extinction coefficient 
of pre-tRNACys. 
 
2.2.4: Fluorescence measurements to determine percent incorporation of thG 
To generate a standard curve, increasing concentrations of thG in 20 mM Tris-HCl (pH 
7.5) were aliquoted into a 384-well black microplate (Nunc) and fluorescence intensity 





Figure 2.5: Efficacy of the Zymo Clean and ConcentratorTM-25 approach to remove 
unincorporated thG. Tubes were illuminated at 312 nm using a Fotodyne UV 
transilluminator to visualize the removal of free thG. FT: flow-through; W1: wash using 
the RNA prep buffer (400 µl); and W2: wash using the RNA wash buffer (700 µl). W3: 
wash using the RNA wash buffer (400 µl). Short RNAs <18 nt are expected to be 





Relative fluorescence units (RFU) were determined by subtracting the background 
fluorescence of blanks lacking thG, and RFU was then plotted against the concentration 
of thG to generate a linear curve-fit (Excel). This standard curve was subsequently used 
to determine the concentration of thG in pre-tRNACys (Figure 2.6). To investigate if there 
was any quenching associated with thG present at the 5' terminus of pre-tRNACys, we 
compared the fluorescence of thG-initiated pre-tRNACys before and after alkaline 
hydrolysis and found that the fluorescence values were nearly indistinguishable (data 
not shown). This finding lends confidence to the estimates of % 5'-modified RNAs that 
were determined from the thG-based standard curve. 
 
2.3: Results 
Prior to comparisons of T7RNAP WT and P2666L mutant, we first confirmed the use of 
roughly equivalent amounts of these variants in our IVTs (Figure 2.7). Because of our 
interest in 5'-incorporation of 5'-deoxy-5'-azido-guanosine (azG), we had performed IVTs 
with this analog and obtained data indicating that percent incorporation was higher 
when the G-analog:GTP ratio was 10:1 compared to 4:1, regardless of whether we used 
the WT or the P266L mutant. This conclusion is also consistent with a previous report 
that used azG.[16] Additionally, by using an IVT spiked with an α-[32P]-labeled rNTP, we 
found that the fraction of short aborted transcripts relative to full-length was significantly 
lower with T7RNAP P266L compared to the WT when azG was the analog (see Chapter 





Figure 2.6: Standard curve used to determine percent incorporation of thG into pre-








Figure 2.7: Purity of recombinant T7RNAP used in this study, as demonstrated by 









Figure 2.8: T7 RNAP P266L yields fewer abortive transcripts than WT when IVTs are 
performed with thG. IVTs to generate pre-tRNACys were performed using either T7 RNAP 
WT or P266L as described in the main text, except each reaction also contained 10 µCi 
of α-32P-GTP (Perkin Elmer, Shelton, CT). Transcription was terminated by addition of a 
loading dye containing 7 M urea and 20% (v/v) phenol. One-tenth of the 20 µL IVT 
reaction was loaded on a 7% (w/v) polyacrylamide/7 M urea gel (40 cm length x 20 cm 
width), and electrophoresed for 75 min at 30 mA. The gel was then exposed for 2 h to a 
phosphorimager screen, and IVT products were visualized using an Amersham 
Typhoon 5 Biomolecular Imager (GE Healthcare). Based on quantitation performed 
using ImageQuant 5.1 software, there is a 1.3-fold increase in the full-length pre-
tRNACys and a corresponding decrease in aborted transcripts.  
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Using a 10:1 ratio of thG:GTP, we determined that T7RNAP WT initiates 40% of 
pre-tRNACys transcripts with thG affording a total RNA yield of 37 µg from a 100 µl IVT 
(Figures 2.9, 2.10, and 2.11). However, when T7RNAP P266L was employed in the 
IVT, thG percent incorporation increased to 85% with a total RNA yield of 50 µg 
(Figures 2.9, 2.10, and 2.11). Thus, the net gain of 5'-thG-modified RNA is ~3-fold. 
While visual inspection post-agarose gel electrophoresis revealed that the IVT yield is 
higher with the P266L mutant compared to the WT (Figure 2.9), the percent 
incorporation of thG in pre-tRNACys was accurately determined by first eliminating the 
unincorporated thG and then measuring the fluorescence in the final RNA product. The 
efficacy of the desalting column in removing the unincorporated thG was evident from 
examining the washes on a trans-illuminator (λexc, 312 nm); the ability to easily monitor 
thG is an appealing feature in its use and allows for rapid visual comparison of its 
incorporation efficiency into RNA across different IVT conditions (Figures 2.5 and 
2.10). While use of the desalting column was essential for complete removal of 
unincorporated thG, we consistently recovered only ~70% of the RNA input to the 
column. Replacing this step with an alternative that results in a lower loss will be 
desirable. 
To synthesize 5'-NAD-capped RNA, Jäschke and coworkers[17] employed an 
elegant multi-pot, chemo-enzymatic approach. Post-IVT, the RNA product was 
subjected to a polyphosphatase treatment to remove the pyrophosphate and yield 5'-
GMP transcripts, which were then reacted with nicotinamide mononucleotide-
phosphorimidazolide. Any unreacted 5'-GMP transcripts were then removed by Xrn-1. 
We have now extended this approach to enhance the fraction of 5'-thG-pre-tRNACys 
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albeit with an OPME set-up. Post-IVT, RppH was utilized to convert 5'-GTP-pre-tRNACys 
into 5'-GMP-pre-tRNACys that was then degraded using commercially available Xrn-1. 
This exonuclease was not expected to act on 5'-thG-pre-tRNACys given the absence of a 
5'-monophosphate. An advantage of the OPME approach is that these enzymes are 
added post-IVT with no intervening processing steps. Our OPME method resulted in 40 
µg of near-homogenous (~95%) 5'-thG-pre-tRNACys from a 100-µl IVT (Figure 2.11). 
That a small fraction of the 5'-GTP initiated pre-tRNACys was not removed indicates that 
the activities of RppH and Xrn-1 may not be optimal under our OPME reaction 
conditions, but these can be tweaked through customized optimization trials. 
Owing to the poor solubility of guanosine in water, the stock of thG was prepared 
in DMSO. The inclusion of 20% DMSO in IVTs was reported to afford an increase in 
RNA yield and fewer variations in 3'-termini (lower 3'-heterogeneity).[18] To test the idea 
that inclusion of DMSO in the IVT might similarly influence the bias of T7RNAP to 
initiate RNAs with thG, we performed IVTs of pre-tRNACys as described above except in 
the presence or absence of 5% DMSO. However, we did not observe any significant 
effect on RNA yield or incorporation of thG upon inclusion of DMSO (Figure 2.12). 
 
2.4: Discussion 
Our results show that the T7RNAP P266L mutant enhances the total RNA yield and 
percent of 5'-thG-initiated RNAs, with additional gains resulting from the post-IVT use of 
RppH and Xrn-1 to selectively remove the 5'-GTP-initiated RNAs. The findings with thG 





Figure 2.9: One aliquot (1 µL) from 100 µL IVT, performed with either T7RNAP WT 
(lane 1) or P266L (lane 2), was electrophoresed on a 2% (w/v) agarose gel and stained 
with ethidium bromide; samples were examined post-DNase I treatment. Lane 3 
contains 1 µg of the final pre-tRNACys that was generated by using the OPME (post-IVT 
RppH and Xrn-1) approach. Unincorporated thG does not electrophorese far into the 






Figure 2.10: Fluorescence (λex =312 nm) of 5 mm RNA obtained after IVT with 






Figure 2.11: RNA yields (gray) and percentage incorporation of thG (purple) with 
T7RNAP WT (1) or P266L (2) or using the OPME method with P266L (3). Mean and 






Figure 2.12: RNA yield and percent incorporation of thG into pre-tRNACys using 
T7RNAP P266L in the absence or presence of 5% (v/v) DMSO. The data reported here 
are from a single IVT trial. 
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with modified nucleosides, an attribute noted before while investigating use of modified 
2'-NTPs.[8] Given the value of thG as a probe of RNA folding/dynamics and RNA 
function,[2] the facile synthesis of 5'-thG-initiated RNAs should increase the use of this 
guanosine isomorph. Moreover, we expect that the OPME approach described here will 
improve percent incorporation and yields of other G-analogs at the 5'-end of RNAs of 
any length and sequence. 
Because the total RNA yield (50 µg/100 µl IVT) of pre-tRNACys from IVTs 
containing thG was ~2.5-fold lower than IVTs containing only 3 mM rNTPs, we sought 
two different approaches to bridge this gap. First, we explored the use of a mutant 
T7RNAP containing 10 mutations (termed ‘RGVG-M6’), including P266L, which 
exhibited a 25-fold increase in RNA yield of fully 2'-modified RNA over other commonly 
used mutant T7RNAPs.[9] When we purified this mutant and tested the recombinant 
version in IVTs, we did not observe an increase in the total yield of 5'-thG-initiated RNAs. 
Second, we examined the effects of retaining the [thG]:[GTP] ratio but increasing their 
absolute concentrations on T7RNAP P266L’s activity. Indeed, changing [thG]:[GTP] from 
4.8 mM:0.48 mM to 10 mM:1 mM led to doubling of the yield of total pre-tRNACys, 
although percent incorporation of thG decreased by one-fourth (duplicate experiments, 
data not shown). A modest compromise in the incorporation of thG is offset by the yield 
payoff especially since the OPME approach helps selectively eliminate the GTP-initiated 
RNA. Due to the template-dependent variability in IVT yields, pilot tests of different 
rNTP concentrations in IVTs as well as different [thG]:[GTP] ratios will be gainful for any 
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Chapter 3: A T7 RNA polymerase mutant enhances the yield of 5'-deoxy-5'-
azidoguanosine-initiated RNAs 
3.1: Background and rationale 
While availability to produce 5'-thG-initiated RNA transcripts using T7RNAP P266L will 
prove useful for many endeavors, other applications such as fluorescence or electron 
paramagnetic resonance (EPR) studies necessitate the incorporation of chemical 
handles that in turn will allow covalent tethering to fluors, spin labels, or other probes. 
The general strategy in these instances entails the use of commercially available probes 
bearing a reactive group (e.g., aldehyde) that allow for their specific conjugation to a 
target biomolecule containing an appropriate reactive group (e.g., a primary amine). 
While there are many approaches to accomplish such site-specific covalent 
modifications, the azide-alkyne “click reaction” that generates a 1,4-disubstituted five-
member 1,2,3-triazole has become a reaction of choice due to its bioorthogonal nature 
and high efficiency.[1-4] Copper(I) is a catalyst for this 1,3-dipolar cycloaddition, although 
it does generate reactive oxygen species that degrade RNA. It is notable that RNAs 
containing a 5'-deoxy-5'-azidoguanosine (azG; Figure 3.1) have been successfully 
‘clicked’ in vitro to Cy5- and fluorescein-alkynes as well as to another RNA having a 3'-
alkyne.[2,5,6] The value of azG for “clicking” to alkynes motivated us to investigate if 
T7RNAP P266L would enhance the yield of 5'-azG-initiated RNAs akin to the gains that 
we observed with thG (see Chapter 2). 
The accurate determination of the percent incorporation of non-fluorescent 
transcriptional initiators in long RNAs is challenging. Many studies have assessed 





Figure 3.1: Structures of guanosine triphosphate and 5'-deoxy-5'-azidoguanosine. 
  
54 
RNA’s fluorescence after conjugation of the G-analog to a fluorophore or retardation of 
the RNA on a polyacrylamide gel after conjugation to biotin/streptavidin.[,6-10] An 
underlying assumption made in this method is that the reaction between the 5'-G-analog 
and the fluorophore or biotin proceeds with 100% efficiency, which is often not the case 
and thus the reported percent incorporation is an underestimate. However, this 
methodology does not account for non-covalent attachment of fluorophore/biotin to the 
target RNA, which would overestimate the percent incorporation of the G-analog. An 
appealing approach to accurately determine percent incorporation of a G-analog at the 
5'-terminus of an RNA exploits the difference in electrophoretic mobility of the RNAs 
bearing either 5'-GTP or 5'-G-analog, made possible by G-analogs that lack the 
negative charges associated with the triphosphate in the GTP initiator. This method, of 
course, is most useful for small RNAs where the differences in the 5'-terminus confer an 
electrophoretic mobility difference that is resolvable in a standard polyacrylamide gel 
(20 x 20 cm). 
To overcome this limitation and accurately determine percent incorporation of azG 
in a long RNA, we first employed either T7RNAP WT or P266L in IVTs containing azG 
and α-[32P]-UTP to transcribe a pre-tRNACys containing a 5-nt, 5'-leader (5'-GGUUU-3'; 
Figure 3.2). Next, we explored using RNase P, an endonuclease that catalyzes the 
removal of the 5'-leader in pre-tRNAs, to generate two 5 nt leaders: one with azG at the 
5'-terminus and the other with 5'-GTP. These short RNAs (5 nts) with two different 
termini were easily resolved on a polyacrylamide gel (Figure 3.3). Using this approach, 
we were able to validate our previous finding that T7RNAP P266L decreased abortive 










Figure 3.3: Schematic of the RNase P-based assay that was developed to assess the 
percent incorporation of azG at the 5'-terminus of pre-tRNACys. Upon RNase P cleavage, 
two different 5-nt leaders are generated: one having 5'-ppp and the other 5'-azG. The 5'-
azG leader is expected to migrate slower than the 5'-ppp leader during PAGE owing to 
its lack of negative charges, thus allowing for direct quantification of percent 





Importantly, T7RNAP P266L enhances both the total RNA yield and percent 
incorporation of azG. Furthermore, we validated that our OPME approach using 
T7RNAP P266L further enriched for 5'-azG-initiated RNA up to 90%. 
 
3.2: Materials and methods 
3.2.1: Overexpression and purification of T7RNAPs WT and P266L 
Both WT and P266L T7RNAPs were overexpressed and purified as described earlier 
(see Chapter 2.2.1 and 2.2.2). 
 
3.2.2: In vitro transcription reactions 
A PCR DNA template containing a class III Φ6.5 promoter and gene encoding for A. 
thaliana mitochondrial pre-tRNACys with a 5-nt 5'-leader and no trailer (Figure 3.2) was 
prepared as previously described.[11] The buffer components, concentrations rNTPs, 
and amount of T7RNAP WT and P266L in IVTs were the same as those described 
earlier (see Chapter 2.2.3 and Figure 2.7). IVTs containing azG were performed using 
4.8 mM azG and either 1.2 mM GTP (4:1 ratio) or 0.48 mM GTP (10:1 ratio). One 
hundred-µL IVTs were performed at 37°C for 5 h. Post-transcription, the DNA template 
was degraded by addition of 10 U of DNase I (Roche) and the samples were 
subsequently subjected to phenol-chloroform extraction. Next, the samples were 
extensively dialyzed at against water at 4°C to remove unincorporated ribonucleotides. 
The samples were recovered and then precipitated by ethanol precipitation. The 
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resulting pellets were resuspended in water and total RNA yield was determined using 
Abs260 measurements on a NanoDrop 2000c spectrophotometer and the extinction 
coefficient of pre-tRNACys. 
To generate pre-tRNACys with an internal radiolabel, 20 µL IVTs were performed 
as described above, except with the inclusion of 25 µCi of α-[32P]-UTP [3000 mCi/mmol; 
PerkinElmer, Waltham, MA]. We chose α-[32P]-UTP because the 5-nt 5'-leader of pre-
tRNACys (5'-GGUUU-3') contains three uridine residues, thus enabling visualization of 
the 5'-leader after post-PAGE regardless of whether the RNA had been initiated with 
azG or GTP. IVTs containing α-[32P]-UTP were performed at 37°C for 3 h and 
subsequently quenched with an equal volume of loading dye containing 7 M urea, 10 
mM EDTA, and 20% (v/v) phenol. The samples were then electrophoresed on an 8% 
(w/v) polyacrylamide/7 M urea gel at 30 mA for 1 h. Bands corresponding to full-length 
pre-tRNACys were excised and eluted in 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM 
EDTA, 0.01% SDS (w/v). The elution was performed at 37°C for 3 h and then overnight 
at 4°C. The eluents were filtered through 0.22 µm cellulose acetate Spin-X centrifuge 
tube filters (Corning Costar, Corning, NY) and then precipitated by ethanol precipitation. 
The radioactivity of the resulting RNA pellets was counted using a Bioscan QC-4000 
XER radioisotope counter (Bioscan, Inc., Washington, D.C.) and the pellets were then 
resuspended in a small volume of water (typically 10 to 20 µl). 
 
3.2.3: Post-transcriptional removal of 5'-ppp RNAs 
The OPME approach was performed essentially as described earlier (see Chapter 2 
section 2.2.3) but with two exceptions. First, the Xrn-1 incubation was performed at 
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37°C for 1.5 h. Second, the reactions were performed in a heat block. Total RNA yields 
of pre-tRNACys generated by the OPME approach were not determined because the 
RNAs were radiolabeled. 
 
3.2.4: RNase P-based assays to determine percent incorporation of azG 
To investigate the relative amounts of pre-RNACys initiated with either azG or GTP, we 
performed an IVT with α-[32P]-UTP and in the presence of azG and GTP. The full-length 
RNA from such an IVT was then cleaved with recombinant A. thaliana PRORP1, the 
protein-only form of RNase P (kindly provided by Dr. Tien-Hao Chen, Gopalan 
laboratory). The RNase P cleavage assay was performed by incubating trace amounts 
of pre-tRNACys RNA with 2 µM PRORP1 in 20 mM HEPES (pH 7.2), 150 mM NaCl, 1 
mM MgCl2, 4 mM DTT, and 5% (v/v) glycerol for 10 min at 24°C.[11] Reactions were 
quenched by adding an equal volume of loading dye containing 7 M urea, 10 mM 
EDTA, and 20% (v/v) phenol, and then electrophoresed on a 20% (w/v) 
polyacrylamide/7 M urea gel (40 cm length x 20 cm width) for 2 h. The gel was then 
exposed for 3 h to a phosphorimager screen and RNase P cleavage products were 
visualized using an Amersham Typhoon 5 Biomolecular Imager (GE Healthcare). 
Percent incorporation of azG was determined using ImageQuant 5.1 software-based 
quantitation of the ratio of the slower migrating (RNAs initiated with 5'-azG) to the faster 





To facilitate comparisons, we used approximately equivalent amounts of T7RNAP WT 
and P266L in our IVTs (see Figure 2.7 in Chapter 2). While processing internally 
radiolabeled pre-tRNACys that was generated from IVTs using T7RNAP WT, we 
observed a substantial increase in aborted transcripts when the azG:GTP ratio was 
increased from 0:1 to 4:1, and a modest increase when the ratio was increased from 4:1 
to 10:1 (Figure 3.4). Using an azG:GTP ratio of 10:1 and either T7RNAP WT or P266L, 
we found that the ratio of full-length RNA:aborted transcript is significantly higher when 
T7RNAP P266L is employed in the IVT (Figure 3.5). These findings mirror our previous 
observation that T7RNAP P266L produced fewer abortive transcripts and more full-
length RNA than T7RNAP WT when using a 10:1 ratio of thG:GTP (see Figure 2.8 in 
Chapter 2). 
Using a 4:1 ratio of azG:GTP, we found that T7RNAP WT incorporated azG into 
43% of pre-tRNACys transcripts with a total RNA yield of 22 µg from a 100 µL IVT 
(Figures 3.6 and 3.9). Increasing the azG:GTP ratio to 10:1 and using T7RNAP WT 
resulted in only a small increase in percent incorporation of azG into pre-tRNACys (52%) 
while total RNA yield decreased to 10 µg (Figures 3.6 and Figure 3.9). In contrast, 
when T7RNAP P266L was used in an IVT with a 4:1 ratio of azG:GTP, percent 
incorporation of azG into pre-tRNACys increased to 60% with a total RNA yield of 42 µg 
(Figures 3.7 and 3.9). After the azG:GTP ratio was increased 10:1, T7RNAP P266L 
initiated 75% of pre-tRNACys although the yield decreased to 29 µg (Figures 3.7 and 
3.9). Therefore, T7RNAP P266L yielded ~2.5-fold more 5'-azG-initiated RNA than 
T7RNAP WT when the azG:GTP ratio was 4:1 ratio and ~4-fold more 5'-azG-initiated-
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RNA than T7RNAP WT when the azG:GTP ratio was 10:1. Furthermore, using the 
OPME approach with T7RNAP P266L and a 10:1 ratio of azG:GTP, we ascertained that 
~90% of the RNA containing a 5'-azG (Figures 3.8 and 3.9), however, RNA yields were 
not determined because the RNAs were radiolabeled. That ~10% of the remaining RNA 
contained a 5'-GTP may reflect sub-optimal functionality of RppH and Xrn-1 were not 
optimal under our reaction conditions, an inference we had drawn previously from IVTs 
with thG (see Chapter 2). 
To ensure that the slower migrating band in the RNase P assays corresponded 
to 5'-azG-initiated RNA, pre-tRNACys that was generated without inclusion of azG was first 
cleaved by RNase P to yield the 5'-GTP-bearing 5-nt leader. Calf intestinal phosphatase 
(CIP) was then used to dephosphorylate the 5'-GTP-bearing 5-nt leader to yield a 5'-OH 

















Figure 3.4: Aborted transcription increases with increasing [azG]:[GTP] ratios in IVTs 
performed with T7RNAP WT. IVTs to generate pre-tRNACys were performed using 
T7RNAP WT with  0:1, 4:1, or 10:1 ratio of azG:GTP. After transcription was terminated, 
samples were electrophoresed on an 8% (w/v) polyacrylamide/7 M urea gel at 30 mA 
for 1 h and full-length pre-tRNACys was gel purified. Prior to excising the full-length RNA 
for gel purification, the gel was exposed to an X-ray film screen and developed in a 





Figure 3.5 T7 RNAP P266L yields fewer aborted transcripts than WT when IVTs are 
performed with azG. IVTs to generate pre-tRNACys were performed using either T7 
RNAP WT or P266L with a 10:1 ratio of azG:GTP. After transcription was terminated, 
samples were electrophoresed on an 8% (w/v) polyacrylamide/7 M urea gel at 30 mA 
for 45 min and the full-length pre-tRNACys was gel purified. Prior to excising the full-
length RNA for gel purification, the gel was exposed to an X-ray film screen and 
developed in a darkroom. Brightness and contrast settings were adjusted to ensure 




Figure 3.6: RNase P cleavage of pre-tRNACys that was generated using T7RNAP WT 
and a 0:1, 4:1, or 10:1 ratio of azG:GTP. Technical replicates are grouped using an 






Figure 3.7: RNase P cleavage of pre-tRNACys that was generated using T7RNAP 
P266L and a 0:1, 4:1, or 10:1 ratio of azG:GTP. Technical replicates are grouped using 






Figure 3.8: RNase P cleavage of pre-tRNACys that was generated using the OPME 
approach with T7RNAP P266L and a 10:1 ratio of azG:GTP. Technical replicates are 





Figure 3.9: RNA yields (gray) and percentage incorporation of azG (purple) from IVTs 
containing 0:1, 4:1, or 10:1 ratio of azG:GTP.  IVTS entailed the use of T7RNAP WT or 
P266L; in the case of the latter, results from the OPME method are also depicted, 
however, RNA yields were not determined because the RNAs were radiolabeled. Mean 







Our results demonstrate that T7RNAP P266L enhances the total RNA yield and percent 
of 5'-azG RNA, and that the OPME approach can further enrich the percent of 5'-azG-
initiated RNA up to 90%. The findings with azG parallel those obtained when thG was the 
G-analog (see Chapter 2), underscoring the remarkable tolerance of T7RNAP P266L to 
generate 5'-G-analog-initiated RNAs. Moreover, the RNase P-based assay offers an 
accurate method to determine the percent incorporation of 5'-G-analogs in long RNAs. 
While we used a pre-tRNA as an ideal model substrate and PRORP as the enzyme for 
the assay, E. coli RNase P has been shown to cleave non-tRNA substrates, provided 
there is an external guide sequence hybridized to the cleavage site (Figure 3.10).[12] 
Thus, any RNA can be assayed for the presence of a modification at the 5'-terminus. 
Our results on the incorporation efficiency of azG into RNA when using T7RNAP 
WT and a 4:1 ratio of azG:GTP are in agreement with a previous study, which employed 
a click reaction between 5'-azG RNA and 6-heptynoyl-p-nitroaniline to determine percent 
incorporation azG and reported that using a 5:1 ratio of azG:GTP results in 36% 
incorporation of azG into a 75-nt RNA.[6] However, Paredes and Das (2011) concluded 
that a 4:1 ratio of azG:GTP resulted in ~100% incorporation of azG at the 5'-terminus of a 
66-nt RNA, as assessed by the small number of unreacted transcripts observed on an 
ethidium bromide-stained polyacrylamide gel after click ligation of the 5'-azG RNA to 
another 3'-alkyne RNA.[10]. While we were not successful in achieving such a high 
incorporation of azG into any RNA transcribed from either T7RNAP WT or P266L during 




Figure 3.10: Schematic of how any target RNA can be made into a substrate by E. coli 
RNase P after hybridization of an external guide sequence that terminates in a purine 
(R) and CCA.[12] This approach could be used to determine percent incorporation of a 
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Chapter 4: Further prospects 
4.1: Broader applications of T7 RNA polymerase P266L 
Our finding that T7RNAP P266L displays an increased tolerance to initiate RNAs with 
G-analogs should motivate the study of other applications with this T7RNAP mutant. 
Many G-analogs are not readily accepted by T7RNAP WT and therefore not widely 
used despite having favorable chemical properties. Hydrazinylguanosine (hydG) is one 
such G-analog that was previously found to be incorporated into only 40% of an 82 nt 
RNA transcript generated by T7RNAP WT.[1] Incorporation of a hydrazine at the 5'-
terminus of an RNA would provide the RNA with a nucleophile that is at least one order 
more reactive than a primary amine, and therefore, allow for the conjugation of various 
probes that are available as isothiocyanate or succinimide derivatives.  
While T7RNAP can initiate transcripts with either GTP (using a class III Φ6.5 
promoter)[2,3] or ATP (using a class II Φ2.5 promoter),[4-6] the polymerase is unable to 
initiate with a pyrimidine. When RNAs with a pyrimidine at the 5'-terminus are desired,  
longer transcripts initiated with GTP are generated by IVTs and appropriately placed 
ribozymes are used to release the downstream, desired RNA with a 5'-pyrimidine.[7] 
However, this method is time-consuming, not 100% efficient, and lowers total RNA yield 
given the transcription cost to make the larger RNA. Therefore, another useful 
application for T7RNAP P266L would be to utilize the enzyme to introduce pyrimidines 
at the 5'-terminus of an RNA by initiation with a CpG or UpG dinucleotide. Such an IVT 
would yield a mixture of transcripts: either 5'-GTP- or CpG/UpG-initiated RNA. The 
OPME approach described in Chapters 2 and 3 could be employed to degrade the 5'-
GTP-initiated RNA. Assessing the percent incorporation of the dinucleotide poses a 
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challenge. However, if a CpthG or UpthG dinucleotide could be synthesized, percent 
incorporation of the dinucleotide and effectiveness of the OPME approach is easily 
determined (as shown in Chapter 2). Alternatively, post-dephosphorylation of the IVT 
products, the RNase P-based assay (described in Chapter 3) could be employed to 
resolve 5 and 6 nt RNAs. 
 
4.2: Other potential methods to improve the incorporation of nucleoside analogs 
Despite the advances with T7RNAP P266L to initiate RNAs with G-analogs, our total 
RNA yield is consistently ~two or three-fold lower than the yield from IVTs lacking a 
triphosphate. Chelliserykattil and Ellington (2004) used a directed-evolution approach to 
select for T7RNAP mutants that displayed the greatest ability to transcribe fully modified 
2'-O-methyl RNA and obtained a panel of mutants whose versatility is still under study.[8-
10] The most active mutants were identified by their ability to transcribe full-length RNA 
when one or more rNTPs were replaced with their 2'-O-methyl-NTP counterpart.[8] A 
similar scheme could be applied to select for T7RNAP mutants that enhance the yield of 
5'-G-analog initiated RNAs (including azG and thG). Such tailor-made mutants together 
with the OPME approach could greatly expand the repertoire of 5'-modifications in 
RNAs generated by IVTs. 
T7RNAP WT has also been reported to successfully accept adenosine analogs 
as transcriptional initiators when using a class II Φ2.5 promoter,[4-6] although RNA yield 
from this promoter is 70% lower than that of the class III Φ6.5 promoter.[11] We 
attempted to use T7RNAP P266L to initiate RNAs with 5'-deoxy-5'-azidoadenosine as 
74 
well as isothiazolo[4,3-d]-adenosine, however, these attempts were unsuccessful (data 
not shown). Our results indicate that the advantage conferred by the P266L mutation to 
enhance the yield of 5'-G-analog initiated RNA when using the class III Φ6.5 promoter 
does not translate to the ATP-initiating promoter. This finding should prompt efforts to 
crystallize the initiation complex of T7RNAP bound to the class II Φ2.5 promoter to 
uncover amino acid residues that are pertinent to the binding of the initiating ATP 
nucleotide. Subsequent computational studies could suggest potential mutations to 
T7RNAP that may improve its propensity to initiate RNAs with A-analogs. Alternatively, 
a directed evolution study could be undertaken to select for T7RNAP mutants that best 
initiate RNAs with ATP. In this approach, a library of mutant T7RNAPs could be 
transformed into E. coli, whose survival depends on the ability to transcribe a house-
keeping RNA (e.g., a tRNA, RNase P) that initiates with an ATP. Advantage-conferring 
T7RNAP mutations would be selected for based on the growth of the E. coli colonies 
and ensuing IVT tests with an A-analog could be used to identify mutants that enhance 
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